Speaking opportunities at our audio conferences and webinars

Does your company cater to the medical device, IVD, pharma, or biotech industries? Are you interested in sharing your expertise with other industry professionals?

The key element to the success of our ongoing FX Conferences audio conference series is the speaker relationships forged behind the scenes. We seek out and partner with thought leaders in the life sciences to bring our audience the latest information and guidance on industry hot topics - topics like regulatory submissions, clinical evaluations, human factors engineering and off-label promotion.

Many of our speaker partners have been working with us for years, having seen tangible value in showcasing their expertise to a targeted audience of life sciences executives. We share with our speakers all of the business development leads arising from each event, and offer the opportunity for revenue sharing as well. We strive to create win-win relationships with our speakers, and many of them have realized business opportunities as a result of their work with us.

Interested in finding out more? Get in touch with Rob Wagner at acsupport@fxtrans.com!

For a detailed proposal on your next clinical, regulatory, or marketing medical translation assignment, contact ForeignExchange Translations.
 

Proof-of-Concept Clinical Trials: How to Maximize the Chances of Your Drug Demonstrating Benefit

Regardless of the pharmaceutical development company, therapeutic area or regulatory pathway taken to get a drug onto the market, at some point there is a need to validate the business and scientific/regulatory case in a “proof-of-concept” clinical trial. If the development program supporting a proof-of-concept trial is done well, then it is up to the drug to demonstrate an acceptable risk-benefit profile.

In this audio conference, our speaker examines the framework necessary to maximize the chance of a successful proof-of-concept trial for a new chemical entity (the hardest case). The session also includes a discussion and case histories of the supporting nonclinical safety program, pharmacokinetic and pharmacodynamic evaluations, maximum tolerated dose issues, study design and endpoints in the context of a regulated industry.

Proof-of-Concept Clinical Trials: How to Maximize the Chances of Your Drug Demonstrating Benefit is being presented by Dr. Scott Oglesby, Director, Scientific Consulting, with Beckloff Associates, a Cardinal Health Company and airs on Tuesday, January 19, 2010. For more details or to register, please visit our site at www.fxconferences.com